Cerevel, a biotech firm, recovered part of its Tuesday gains following positive test findings for a schizophrenia medicine./n
Read MoreCerevel Stock Returns Some Of Its Triple-Digit Gains On Schizophrenia Results
2021-06-30T15:43:27-04:00June 30th, 2021|
Related Posts
-
How the computer games industry is embracing AI
May 2nd, 2024 -
Apple sales see biggest fall in a year
May 2nd, 2024